NAV Growth

Growth of each fund's NAV over the selected period, rebased to 0%

Growth of each fund's NAV over the selected period, rebased to 0%

‌

Fund Details

Fund Details	DSP Healthcare Fund - Direct (G)
Fund Type	Equity
Risk	Very High
Min SIP Amount	₹100
Min Lumpsum	₹100
Expense Ratio	0.75%
NAV	₹52.66 (09 Nov 2026)
Fund Size	₹3,727.17 Cr
Fund Started	30 Nov 2018
Lock-in Period	No lock-in
Exit Load	0.50%If redeemed/switched out within 1 months from the date of allotment NilIf redeemed/switched out after 1 months from the date of allotment

Trailing risk-adjusted performance measures

Name	Assets
Apollo Hospitals En...Equity	7.89%
Ipca Laboratories LtdEquity	7.49%
Cipla LtdEquity	7.40%
Sun Pharmaceutical ...Equity	7.32%
Gland Pharma LtdEquity	6.61%
Sai Life Sciences LtdEquity	6.17%
Globus Medical IncForeign Equity	5.36%
Alkem Laboratories LtdEquity	4.73%
Divis Laboratories LtdEquity	4.41%
Cohance Lifescience...Equity	3.82%

Fund Manager	DSP Healthcare Fund - Direct (G)
Name
Managing Since	01 Dec 2020